An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
By L. Verdoni, A. Mazza, A. Gervasoni, L. Martelli, M. Ruggeri, M. Ciuffreda, E. Bonanomi, L. D’Antiga. The Lancet, 2020
2,068 citations recorded by the source corpus.
Background The Bergamo province, which is extensively affected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic, is a natural observatory of virus manifestations in the general population. In the past month we recorded an outbreak of Kawasaki disease; we aimed to evaluate incidence and features of patients with Kawasaki-like disease diagnosed during the SARS-CoV-2 epidemic. Methods All patients diagnosed with a Kawasaki-like disease at our centre in the past 5 years were divided according to symptomatic presentation before (group 1) or after (group 2) the beginning of the SARS-CoV-2 epidemic. Kawasaki- like presentations were managed as Kawasaki disease according to the American Heart Association indications. Kawasaki disease shock syndrome (KDSS) was defined by presence of circulatory dysfunction, and macrophage activation syndrome (MAS) by the Paediatric Rheumatology International Trials Organisation criteria. Current or previous infection was sought by reverse-transcriptase quantitative PCR in nasopharyngeal and oropharyngeal swabs, and by serological qualitative test detecting SARS-CoV-2 IgM and IgG, respectively. Findings Group 1 comprised 19 patients (seven boys, 12 girls; aged 3·0 years [SD 2·5]) diagnosed between Jan 1, 2015, and Feb 17, 2020. Group 2 included ten patients (seven boys, three girls; aged 7·5 years [SD 3·5]) diagnosed between Feb 18 and April 20, 2020; eight of ten were positive for IgG or IgM, or both. The two groups differed in disease incidence (group 1 vs group 2, 0·3 vs ten per month), mean age (3·0 vs 7·5 years), cardiac involvement (two of 19 vs six of ten), KDSS (zero of 19 vs five of ten), MAS (zero of 19 vs five of ten), and need for adjunctive steroid treatment (three of 19 vs eight of ten; all p<0·01). Interpretation In the past month we found a 30-fold increased incidence of Kawasaki-like disease. Children diagnosed after the SARS-CoV-2 epidemic began showed evidence of immune response to the virus, were older, had a higher rate of cardiac involvement, and features of MAS. The SARS-CoV-2 epidemic was associated with high incidence of a severe form of Kawasaki disease. A similar outbreak of Kawasaki-like disease is expected in countries involved in the SARS-CoV-2 epidemic. Funding None.
Subfields: Infectious Diseases, Surgery
View Paper: https://www.semanticscholar.org/paper/0fa2585468ccf948b2975fa1568dd614fd0c7d57
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- B. Gallo Marin
- Ghazal Aghagoli
- Katya Lavine
- Lanbo Yang
- Emily J. Siff
- S. Chiang
- T. Salazar-Mather
- T. Flanigan
Citations in the corpus
- Predictors of COVID-19 severity: A literature review (2020, background): “lymphopenia, and elevated ferritin and triglycerides were commonly observed in patients with MIS-C.(126)”
- Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. (2020, neutral): “Respiratory Intubation 25 (43) 2 (9) 23 (79) 2 (7) 5 (38) 20 (44) 1 (14) 24 (47) 5 (63) 20 (40) 20 (45) 5 (36) Pharmacotherapy Intravenous immunoglobulin 41 (71) 14 (61) 21 (72) 20 (69) 13 (100) 28 (62) 7 (100) 34 (68) 8 (100) 33 (66) 33 (75) 8 (57) Corticosteroids 37 (64) 12 (52) 19 (66) 18 (62) 12”
- The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 (2020, neutral): “Informed consent was obtained from parents or guardians of all patients both in Sweden and Italy.”